Lupus Erythematosus, Systemic: all 1,222 studies
Page 10 of 13. Open to participants first (399), then studies with results posted, then the rest; newest registration first within each.
- Personalised Pharmacological Approach to the Tapering of Corticosteroid Doses in Systemic Lupus Patients Treated With PrednisoneCompletedNCT03187743Not applicable
- Long Non Coding RNA in Complications of Systemic LupusStatus unknownNCT03185767Not applicable
- Cardiac and Laboratory Findings in Patients With Systemic Lupus ErythematosusCompletedNCT03179046
- Regulatory BCells in Systemic Lupus ErythematosusStatus unknownNCT03178721
- Efficacy of 595 nm Pulsed-dye Laser in Treatment of Discoid Lupus ErythematosusStatus unknownNCT03178188Phase 2/3
- Pilot Trial of Mesenchymal Stem Cells for Systemic Lupus ErythematosusCompletedNCT03171194Phase 1
- Systemic Lupus and Adverse Pregnancy OutcomeStatus unknownNCT03171103
- Fatigue, Depression, and Cortical Excitability in Systemic LupusStatus unknownNCT03165682
- Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE)TerminatedNCT03159936Early Phase 1
- Effect Of Curcuma Xanthorrhiza and Vitamin D3 Supplementation in SLE Patients With Hypovitamin DCompletedNCT03155477Not applicable
- Improving the Assessment of SLE Disease ActivityCompletedNCT03144063
- Validation of a Mobile Phone Based on EPRO Tool in Subjects With Systemic Lupus ErythematosusCompletedNCT03142711
- Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment OptimizationStatus unknownNCT03142412
- Compassionate Use for Subcutaneous (SC) BelimumabNo longer availableNCT03125486
- Pilot Study to Investigate Contemplative Intervention in Lupus PatientsCompletedNCT03103243Not applicable
- A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLECompletedNCT03098823Phase 4
- Anti-ficolin-2 Autoantibodies in Lupus NephritisCompletedNCT03063281
- Rituximab Objective Outcome Measures Trial in SLEStatus unknownNCT03054259Phase 2
- Prophylactic Trimethoprim/Sulfamethoxazole to Prevent Severe Infections in Patients With Lupus ErythematousStatus unknownNCT03042260Phase 4
- Detection of Annexin A2 in Systemic Lupus ErythematosusCompletedNCT03031925Not applicable
- A Study of CD19 Redirected Autologous T Cells for CD19 Positive Systemic Lupus Erythematosus (SLE)Status unknownNCT03030976Phase 1
- Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary RaynaudCompletedNCT03027674Early Phase 1
- ILT-101 in Patients With Active Moderate to Severe Systemic Lupus Erythematosus (SLE)CompletedNCT02955615Phase 2
- Dissemination of the Lupus Interactive NavigatorCompletedNCT02950714Not applicable
- Anti-infection of Low-does IL-2 in SLECompletedNCT02932137Not applicable
- Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory DiseasesCompletedNCT02925351Early Phase 1
- Comparison of the Clinical Examination and the Joint Ultrasonography in Lupus PatientsCompletedNCT02922114Not applicable
- A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-56022473 in Subjects With Systemic Lupus ErythematosusWithdrawnNCT02920424Phase 1
- Prospective Maternal Surveillance of SSA (Sjögren Syndrome A) Positive Pregnancies Using a Hand-held Fetal Heart Rate MonitorCompletedNCT02920346
- Study of the Role of Soluble Forms of RAGE (sRAGE/esRAGE) as Diagnostic and Prognostic Biomarkers of Systemic Lupus Erythematosus.Status unknownNCT02891213
- Study of RC18 Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE)CompletedNCT02885610Phase 2
- Effect of Green Tea on Treatment of LupusCompletedNCT02875691Phase 2
- Prediction of Relapse Risk in Stable Systemic Lupus ErythematosusCompletedNCT02842814Not applicable
- LUMIER² Study : LUpus Molecular Immunomonitoring to Evaluate the Risk of RelapseTerminatedNCT02811094Not applicable
- Observational Multicenter Case-control Study to Assess Nailfold Capillary Abnormalities in Systemic Lupus ErythematosusCompletedNCT02801812
- Determination of the RANKL/Osteoprotegerin Ratio in Patients With Systemic Lupus Erythematosus. Role in Osteoporosis and Cardiovascular CalcificationCompletedNCT02799173Not applicable
- Register of Patients With Anti-Phospholipids Syndrome (APS) and/or Systemic Lupus Erythematosus (SLE)CompletedNCT02782039
- Acthar SLE (Systemic Lupus Erythematosus)WithdrawnNCT02779153Phase 4
- Utility of a Measure of Lupus Low Disease Activity State (LLDAS) in SLECompletedNCT02769195
- Circulating MicroRNAs in Understanding Pathogenesis of Systemic Lupus ErythematosisCompletedNCT02756546Phase 1/2
- The Effect of Metformin on Reducing Lupus FlaresCompletedNCT02741960Phase 4
- Safety and Efficacy of Adipose Derived Stem Cells in Refractory Rheumatoid Arthritis, Systemic Lupus Erythematosus or Sharp's SyndromeTerminatedNCT02741362Phase 1
- Effect of Qi Gong Training on Quality of Life in Patients With Systemic Lupus Erythematous (LuQi)CompletedNCT02732470Not applicable
- TAB08 in Patients With Systemic Lupus Erythematosus (SLE), Not Adequately Controlled With Current TreatmentTerminatedNCT02711813Phase 2
- Autologous EBV-specific Cytotoxic T Cells for the Treatment of Systemic Lupus Erythematosus (SLE)TerminatedNCT02677688Phase 1/2
- Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus ErythematosusCompletedNCT02656082Phase 2
- The Impact of Illness Perceptions on Health Related Outcomes in Patients With Lupus and Systemic SclerosisCompletedNCT02655640
- Lupus Intervention for Fatigue TrialActive, not recruitingNCT02653287Not applicable
- Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)CompletedNCT02633163Phase 2
- Walk With Ease Program For Patients With Systemic Lupus ErythematosusCompletedNCT02631005Not applicable
- Anti-ficolin-3 Autoantibodies in Lupus NephritisCompletedNCT02625831
- A Single Ascending Dose Study in Healthy Participants and Multiple Dose Study of JNJ-55920839 in Participants With Mild to Moderate Systemic Lupus ErythematosusCompletedNCT02609789Phase 1
- Evaluation of the Discontinuation of Maintenance Corticosteroid Treatment in Quiescent Systemic LupusStatus unknownNCT02558517Phase 3
- MSC2364447C Phase 1b in Systemic Lupus ErythematosusCompletedNCT02537028Phase 1
- Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Systemic Lupus ErythematosusCompletedNCT02535689Phase 1
- Web-based Genetic Research on LupusCompletedNCT02530944
- Tissue Sodium in Autoimmune DiseaseWithdrawnNCT02525835Not applicable
- Omega 3 Fatty Acids and Systemic Lupus ErythematosusCompletedNCT02524795Not applicable
- CHABLIS7.5: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without NephritisTerminatedNCT02514967Phase 3
- 3,3'-Diindolylmethane in Patients With Systemic Lupus ErythematosusTerminatedNCT02483624Phase 1
- Long-term Immunogenicity of a HPV Vaccine in SLECompletedNCT02477254
- Safety and Immunogenicity of a Zoster Vaccine in SLECompletedNCT02477150Phase 4
- Phenomics in Autoimmune and Inflammatory DiseasesCompletedNCT02466217
- A Pilot-Study With Low-dose hrIL-2 for the Treatment of Systemic Lupus ErythematosusStatus unknownNCT02465580Phase 2
- Development of a Novel Glutamate Receptor Ligand for PET Scans in Neuropsychiatric Systemic Lupus ErythematosusCompletedNCT02456168
- Prognosis Assessment of the Increase of GADD34 Gene Expression for Patient Suffering From Systemic Lupus ErythematosusCompletedNCT02455089Not applicable
- Web-based CBT for Symptoms of Mild-to-Moderate Anxiety and Depression in Youth With Chronic IllnessCompletedNCT02453880Not applicable
- Pregnancy and Medically Assisted Conception in Rare DiseasesWithdrawnNCT02450396
- A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of Single Dose of AMG 623 in Subjects With Systemic Lupus ErythematosusCompletedNCT02443506Phase 1
- Denosumab for Glucocorticoid-treated Children With Rheumatic DisordersWithdrawnNCT02418273Phase 1/2
- A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of AMG 623 in Subjects With Systemic Lupus ErythematosusCompletedNCT02411136Phase 1
- Prediction of Outcome of Lupus NephritisStatus unknownNCT02403115
- A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus ErythematosusCompletedNCT02391259Phase 1
- Prospective Evaluation of Decision and Compliance With Antimalarials in Patients With Systemic LupusCompletedNCT02364908Not applicable
- Study During Pregnancy of Expression of miRNAs in RA or SLECompletedNCT02350491
- Pharmacodynamics Assessment Study After Single Subcutaneous Dose Of SAR113244 Versus Placebo In Lupus Male And Female PatientsWithdrawnNCT02331810Phase 1
- Effectiveness of Pharmaceutical Care in the Adherence of Systemic Lupus Erythematosus TreatmentCompletedNCT02330250Not applicable
- Multiple Ascending Dose Study To Assess The Safety Profile Of SAR113244 Versus Placebo In Lupus Male And Female PatientsCompletedNCT02321709Phase 1
- Exploratory Study of MT-1303 in Systemic Lupus Erythematosus PatientsCompletedNCT02307643Phase 1
- Study to Compare Properties of Epratuzumab When Given as an Injection Under the Skin or Directly Into the BloodCompletedNCT02306629Phase 1
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus ErythematosusCompletedNCT02291588Phase 1
- Synergetic B-cell Immodulation in SLECompletedNCT02284984Phase 2
- Activity and Nutrition Trial in Lupus to Energize and RenewCompletedNCT02281513Not applicable
- Evaluation of Belimumab Impact on a BLyS Activity Signature Test in the Absence of Confounding PolypharmacyStatus unknownNCT02270970Phase 4
- Molecular Mechanisms Characteristics in Systemic Lupus Erythematous Autoimmune DiseaseWithdrawnNCT02270710
- A Complex Contraception RegistryCompletedNCT02219269
- Tear Proteins, Conjunctival Cells and Imaging Eyes in Rheumatoid Arthritis and Systemic Lupus Erythematosus PatientsCompletedNCT02217137
- Dose Escalation Study of RSLV-132 in Subjects With Systemic Lupus ErythematosusCompletedNCT02194400Phase 1
- Dose-escalation Trial of Anti-C5aR Antibody in Healthy SubjectsCompletedNCT02151409Phase 1
- Pilot Tape Harvesting StudyCompletedNCT02125695
- Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Single Doses and Multiple Doses of BIIB059 (Litifilimab) in Healthy Volunteers and Participants With Systemic Lupus ErythematosusCompletedNCT02106897Phase 1
- Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB)TerminatedNCT02102594Phase 2
- CHABLIS-SC2: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without NephritisWithdrawnNCT02074020Phase 3
- Aerobic Exercise on Improving Sleep in Systemic Lupus Erythematosus.Status unknownNCT02037971Not applicable
- A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy VolunteersCompletedNCT02034344
- Pilot Study - Effect of Omega-3 on Systemic Lupus ErythematosusCompletedNCT02021513Phase 2
- Pilot Study to Assess Flares Following Inactivated Influenza Vaccine in Children With Systemic Lupus Erythematosus (SLE)CompletedNCT02006784
- GENetic & Immunologic Abnomalies in Systemic Lupus ErythematosusCompletedNCT01992666Not applicable
- Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory DiseasesCompletedNCT01988506Phase 2
- Omega 3 in LES and APSStatus unknownNCT01956188Not applicable